D-1566-2020 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- September 16, 2020
- Initiation Date
- August 24, 2020
- Termination Date
- December 16, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 38,487 bottles
Product Description
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
Reason for Recall
Sub-Potent Drug: Out of specification test results for potency (below specification).
Distribution Pattern
Nationwide in the U.S. and Puerto Rico.
Code Information
Lot #: 30310638A, Exp. 02/2022